Class information for:
Level 1: INFLAMMASOME//NLRP3//CASPASE 1

Basic class information

Class id #P Avg. number of
references
Database coverage
of references
2156 2339 55.2 95%



Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes

The table includes all classes above and classes immediately below the current class.



Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
449 3       FAMILIAL MEDITERRANEAN FEVER//TOLL LIKE RECEPTORS//INFLAMMASOME 25887
2102 2             FAMILIAL MEDITERRANEAN FEVER//INFLAMMASOME//NLRP3 5151
2156 1                   INFLAMMASOME//NLRP3//CASPASE 1 2339

Terms with highest relevance score



rank Term termType Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 INFLAMMASOME authKW 3026853 23% 44% 528
2 NLRP3 authKW 1244576 8% 53% 179
3 CASPASE 1 authKW 962116 9% 36% 205
4 NLRP3 INFLAMMASOME authKW 763741 5% 47% 125
5 PYROPTOSIS authKW 440499 3% 50% 67
6 ASC authKW 351021 3% 39% 69
7 NOD LIKE RECEPTORS authKW 319351 3% 37% 66
8 NLRP1 authKW 238097 1% 79% 23
9 AIM2 authKW 236884 1% 55% 33
10 CARD8 authKW 159897 1% 88% 14

Web of Science journal categories



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 Immunology 18230 42% 0% 994
2 Cell Biology 3401 21% 0% 487
3 Biochemistry & Molecular Biology 1563 25% 0% 578
4 Medicine, Research & Experimental 422 6% 0% 144
5 Virology 395 4% 0% 85
6 Microbiology 369 7% 0% 156
7 Parasitiology 331 3% 0% 61
8 Rheumatology 310 2% 0% 56
9 Infectious Diseases 94 3% 0% 63
10 Biophysics 56 3% 0% 69

Address terms



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 MOL BACTERIOL IMMUNOL 66073 0% 56% 9
2 VET PATHOL CORE 64801 1% 41% 12
3 INFLAMMAT PROGRAM 56244 1% 13% 34
4 UNIT INNATE IMMUN 46615 0% 71% 5
5 INNATE IMMUN 44111 1% 11% 30
6 MED PROT 42942 2% 8% 43
7 UNIT CLIN BIOCHEM 42093 0% 32% 10
8 MED INVEST DERMATOL IMMUNODEFICIENCY 40787 0% 63% 5
9 OPTOSIS CANC IMMUNOL AKIL 29368 0% 75% 3
10 MOL ONCOL ANGIOL 29356 0% 25% 9

Journals



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 NATURE IMMUNOLOGY 14722 2% 2% 50
2 IMMUNITY 9449 2% 1% 50
3 CELL HOST & MICROBE 7576 1% 2% 25
4 JOURNAL OF IMMUNOLOGY 6537 7% 0% 166
5 FRONTIERS IN IMMUNOLOGY 3732 1% 1% 29
6 SEMINARS IN IMMUNOPATHOLOGY 3222 0% 2% 11
7 IMMUNOLOGICAL REVIEWS 3040 1% 1% 27
8 NATURE REVIEWS IMMUNOLOGY 2377 1% 1% 14
9 TRENDS IN IMMUNOLOGY 1957 1% 1% 14
10 PLOS PATHOGENS 1817 1% 1% 28

Author Key Words



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
LCSH search Wikipedia search
1 INFLAMMASOME 3026853 23% 44% 528 Search INFLAMMASOME Search INFLAMMASOME
2 NLRP3 1244576 8% 53% 179 Search NLRP3 Search NLRP3
3 CASPASE 1 962116 9% 36% 205 Search CASPASE+1 Search CASPASE+1
4 NLRP3 INFLAMMASOME 763741 5% 47% 125 Search NLRP3+INFLAMMASOME Search NLRP3+INFLAMMASOME
5 PYROPTOSIS 440499 3% 50% 67 Search PYROPTOSIS Search PYROPTOSIS
6 ASC 351021 3% 39% 69 Search ASC Search ASC
7 NOD LIKE RECEPTORS 319351 3% 37% 66 Search NOD+LIKE+RECEPTORS Search NOD+LIKE+RECEPTORS
8 NLRP1 238097 1% 79% 23 Search NLRP1 Search NLRP1
9 AIM2 236884 1% 55% 33 Search AIM2 Search AIM2
10 CARD8 159897 1% 88% 14 Search CARD8 Search CARD8

Core articles

The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.



Rank Reference # ref. in
cl.
Shr. of ref. in
cl.
Citations
1 LATZ, E , XIAO, TS , STUTZ, A , (2013) ACTIVATION AND REGULATION OF THE INFLAMMASOMES.NATURE REVIEWS IMMUNOLOGY. VOL. 13. ISSUE 6. P. 397-411 114 75% 495
2 MAN, SM , KANNEGANTI, TD , (2015) REGULATION OF INFLAMMASOME ACTIVATION.IMMUNOLOGICAL REVIEWS. VOL. 265. ISSUE 1. P. 6 -21 167 80% 41
3 TSUCHIYA, K , HARA, H , (2014) THE INFLAMMASOME AND ITS REGULATION.CRITICAL REVIEWS IN IMMUNOLOGY. VOL. 34. ISSUE 1. P. 41 -80 194 80% 14
4 BROZ, P , DIXIT, VM , (2016) INFLAMMASOMES: MECHANISM OF ASSEMBLY, REGULATION AND SIGNALLING.NATURE REVIEWS IMMUNOLOGY. VOL. 16. ISSUE 7. P. 407 -420 108 84% 14
5 SHARMA, D , KANNEGANTI, TD , (2016) THE CELL BIOLOGY OF INFLAMMASOMES: MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION.JOURNAL OF CELL BIOLOGY. VOL. 213. ISSUE 6. P. 617 -629 133 83% 7
6 JO, EK , KIM, JK , SHIN, DM , SASAKAWA, C , (2016) MOLECULAR MECHANISMS REGULATING NLRP3 INFLAMMASOME ACTIVATION.CELLULAR & MOLECULAR IMMUNOLOGY. VOL. 13. ISSUE 2. P. 148 -159 99 78% 19
7 DE ZOETE, MR , PALM, NW , ZHU, S , FLAVELL, RA , (2014) INFLAMMASOMES.COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY. VOL. 6. ISSUE 12. P. - 166 77% 28
8 MAN, SM , KANNEGANTI, TD , (2016) CONVERGING ROLES OF CASPASES IN INFLAMMASOME ACTIVATION, CELL DEATH AND INNATE IMMUNITY.NATURE REVIEWS IMMUNOLOGY. VOL. 16. ISSUE 1. P. 7 -21 118 62% 18
9 GUO, HT , CALLAWAY, JB , TING, JPY , (2015) INFLAMMASOMES: MECHANISM OF ACTION, ROLE IN DISEASE, AND THERAPEUTICS.NATURE MEDICINE. VOL. 21. ISSUE 7. P. 677 -687 89 65% 132
10 LAMKANFI, M , DIXIT, VM , (2014) MECHANISMS AND FUNCTIONS OF INFLAMMASOMES.CELL. VOL. 157. ISSUE 5. P. 1013 -1022 79 74% 264

Classes with closest relation at Level 1



Rank Class id link
1 10685 NOD2//NOD1//BLAU SYNDROME
2 25600 IFI16//HIN 200//P202
3 1684 FAMILIAL MEDITERRANEAN FEVER//MEFV//PERIODIC FEVER
4 23666 IL 37//INTERLEUKIN 37//IL 36
5 4871 INTERLEUKIN 18//IL 18//INTERLEUKIN 18 BINDING PROTEIN
6 2033 RIG I//MAVS//MDA5
7 10004 NECROPTOSIS//RIP3//RIP1
8 30473 RS3783553//MICROENCAPSULATED CELLS//ABORAT INNOVAT HEMATOLMINIST HLTHAFFILI
9 3783 P2X7 RECEPTOR//P2X7//P2X7R
10 10327 AUTOPHAGY//XENOPHAGY//LC3 ASSOCIATED PHAGOCYTOSIS

Go to start page